Korea

The World's Third-largest National Pension Service (NPS) to Support Proposals from Korea Zinc's Current Management at the EGM

SEOUL, South Korea, Jan. 20, 2025 /PRNewswire/ -- Korea Zinc has announced that the National Pension Service (NPS) has decided on its voting direc...

2025-01-20 18:48 3029

THE KOREA INDUSTRY DAILY: WOOJIN PLAIMM Advances Global Competitiveness with 'Super-Foam' Technology

SEOUL, South Korea, Jan. 17, 2025 /PRNewswire/ -- WOOJIN PLAIMM, a renowned manufacturer of injection molding machines, is fortifying its global presence by leveraging its innovative 'Super-Foam' and 'Clean-Foam' technologies. These advancements, co-developed in collaboration with the company's A...

2025-01-17 21:00 6586

THE KOREA INDUSTRY DAILY: Twinny and TeamFresh Collaborate to Enhance Logistics Center Productivity with Autonomous Picking Solution

SEOUL, South Korea, Jan. 17, 2025 /PRNewswire/ -- Cold chain logistics company TeamFresh (CEO Seong-il Lee) has partnered with autonomous robot specialist Twinny (Co-CEOs Hong-seok Cheon and Young-seok Cheon) to implement Twinny's "NarGo Order Picking" solution, aiming to boost the productivity o...

2025-01-17 21:00 6938

K-beauty platform hwahae Surpasses 100,000 MAU Two Months After Global Website Launch

* Over 80% of users based in the U.S., with the ranking page drawing the highest engagement * Japanese version to be launched in Q1 2025, strengthening its role as a bridge between K-beauty brands and global consumers SEOUL, South Korea, Jan. 17, 2025 /PRNewswire/ -- Birdview Co., Ltd. (Co-CE...

2025-01-17 21:00 6900

Korea Zinc's Nickel Sulfate Manufacturing Technology Is Recognized as National Strategic Technology

SEOUL, South Korea, Jan. 17, 2025 /PRNewswire/ -- Korea Zinc  (KRX:010130) announced today that its nickel sulfate manufacturing technology has been designated as  "national strategic technology" by the South Korean government. The government recently expanded th...

2025-01-17 17:39 3284

LOTTE BIOLOGICS to Present at the 2025 J.P. Morgan Healthcare Conference

* New CEO James Park Delivers First Presentation at J.P. Morgan Healthcare Conference on "Advancing as a Global CDMO Leader" * Unveiling of Next-Generation ADC Platform 'SoluFlex Link': Enabling High-Potency, High-Yield ADC Development and Manufacturing * Incheon Songdo Bio Campus Plant 1 Un...

2025-01-17 07:11 1938

LG Display Unveils 4th-Generation OLED Panel Optimized for AI Era

SEOUL, South Korea, Jan. 15, 2025 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, continues to lead the way in large-sized OLED technology by unveiling its fourth-generation OLED TV panel. 33% brighter than the previous generation and optimized for the AI TV era...

2025-01-16 10:00 1674

STRADVISION Introduces Data Management Workflow Model to Accelerate Mass Production of 'SVNet 3D Perception Network'

* Enhancing 3D Data Processing Efficiency to Propel Next-Generation Algorithm Development of 3D Perception Network SEOUL, South Korea, Jan. 15, 2025 /PRNewswire/ --STRADVISION , a leader in deep learning-based vision perception technology, today announced the ...

2025-01-16 00:00 2391

Mfive, a Korean road studs supplier, targets global market with its excellent products

SEOUL, South Korea, Jan. 15, 2025 /PRNewswire/ -- Mfive, a supplier specializing in road studs, is attracting attention in domestic and international markets for its excellent technology and products for road safety. Mfive is leading the way in enhancing the safety of drivers and pedestrians by ...

2025-01-15 23:00 2245

NEXTBIOMEDICAL Receives IDE Approval from FDA for Nexsphere-F™, an Embolic Microsphere for Use in Genicular Artery Embolization (GAE) for Knee Osteoarthritis: The U.S. RESORB Trial Launches

SEOUL, South Korea, Jan. 15, 2025 /PRNewswire/ -- NEXTBIOMEDICAL CO., LTD, a KOSDAQ-listed innovative medical device company inSouth Korea, proudly announced that it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) for its clinical tria...

2025-01-15 22:00 2494

Celltrion unveils strategic vision for advancing its innovative drug pipeline at the 43rd Annual J.P. Morgan Healthcare Conference

* Celltrion unveils strategic roadmap for the first time outlining its innovative drug development strategy and its plan to submit 13 Investigational New Drug (IND) application by 2028 * Company reinforces its commitment to a two-pillar growth strategy focusing on its groundbreaking new drug ...

2025-01-15 10:52 1631

South Korea's WIRobotics Takes the Spotlight at CES 2025, Plans Global Expansion

YONGIN, South Korea, Jan. 14, 2025 /PRNewswire/ -- WIRobotics, the company behind the revolutionary wearable mobility solutionWIM(We Innovate Mobility), has achieved a major milestone at CES 2025, one of the world's premier technology trade shows. Featuring more than 4,500 companies from 166 coun...

2025-01-15 01:00 2067

Korea's Leading Indie Beauty Brand d'Alba, Reaches New Heights Globally with 210% Overseas Sales Surge

SEOUL, South Korea, Jan. 14, 2025 /PRNewswire/ -- Premium vegan beauty brand d'Alba has achieved significant growth in its overseas sales, rising  to approximatelyKRW 150 billion won (USD 100 million) in 2024 - which is a 210% growth compared to the previous year. With this growth, d'Alba's inter...

2025-01-14 21:00 1794

ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS

SEOUL, South Korea, Jan. 14, 2025 /PRNewswire/ -- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for 'Pemziviptadil (development code name PF1804),' a treatment for DMD (Duchenne Muscular Dystrophy) cardiomyopathy, from the U.S. Food and Drug Administration...

2025-01-14 21:00 2060

LG Innotek Reasserts Its Leadership in the Future Mobility Market at CES 2025

* Exhibition booth attracts 65,000 cumulative visitors, showcasing innovative mobility components * Innovative technologies presented through a 'User-Centric storytelling' approach elicit strong acclaim, inquiries from visiting customers ensue SEOUL, South Korea, Jan. 13, 2025 /PRNewswire/ --...

2025-01-13 22:00 1587

COSRX Celebrates Global Success at SeoulCon's K-Beauty Boost Event

NEW YORK, Jan. 13, 2025 /PRNewswire/ -- COSRX, a trailblazer in the K-Beauty industry, wrapped up 2024 on a high note by participating in the K-Beauty Boost at SeoulCon, a prominent year-end creator conference hosted by the Seoul Metropolitan Government and Seoul Business Agency (SBA). The event ...

2025-01-13 17:22 1833

Popular Hwacheon ice fishing festival opens in Gangwon Province

HWACHEON, South Korea, Jan. 12, 2025 /PRNewswire/ -- The 2025 Hwacheon Sancheoneo Ice Festival, one ofSouth Korea's most popular winter events, kicked off last Saturday in the northeastern county of Hwacheon, offering nearly a month of ice fishing and seasonal activities.

2025-01-13 12:33 1557

SN BioScience Propels SNB-101 to Phase 2 with IND Clearance from FDA

SEOUL, South Korea, Jan. 10, 2025 /PRNewswire/ -- SN BioScience today announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for a Phase1b/2 clinical trial. This achievement follows the designation of SNB-101 as...

2025-01-10 14:40 1276

LG Energy Solution to Exclusively Supply Cylindrical Batteries for Aptera's Solar Electric Vehicles

* LG Energy Solution signs battery cell supply agreement with Aptera and CTNS * The company will supply 2170 cylindrical battery cells over seven years for the 'Aptera,' aimed to launch in the U.S. market in 2025 * The company secures leadership in the emerging solar EV sector through diff...

2025-01-10 00:00 1872

Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development

* Samsung Biologics to offer ADC services at new dedicated facility * Extended collaboration reflects successful partnership and expertise INCHEON,South Korea, Jan. 8, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO),...

2025-01-09 08:57 1304
12345 ... 116

Week's Top Stories